Related Experiment Video
Updated: May 20, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
[Lung disease associated with connective tissue disease].
R Ysamat Marfá1, A Benito Ysamat, S Espejo Pérez
1Servicio de Radiología, Hospital Universitario Reina Sofía, Córdoba, España. roserysamat@gmail.com
Radiologia
|July 24, 2012
Summary
Connective tissue diseases frequently cause serious lung conditions. High-resolution CT aids in diagnosing interstitial pneumonia and guiding treatment for these pulmonary manifestations.
Area of Science:
- Pulmonary Medicine
- Rheumatology
- Radiology
Background:
- Connective tissue diseases (CTDs) are frequently linked to significant lung conditions, impacting patient morbidity and mortality.
- Pulmonary manifestations in CTDs include interstitial lung disease, airway disease, pleural lesions, and vascular disease.
- Early detection and accurate diagnosis are crucial for managing these complex conditions.
Purpose of the Study:
- To highlight interstitial pneumonia associated with connective tissue disease.
- To differentiate CTD-related interstitial pneumonia from idiopathic forms.
- To provide radiologists with a practical guide for diagnosing and managing pulmonary manifestations in CTD patients.
Main Methods:
- Review of high-resolution computed tomography (HRCT) findings in CTD-associated lung disease.
- Emphasis on differentiating features of interstitial pneumonia in CTD versus idiopathic interstitial pneumonia.
- Comprehensive overview of common pulmonary manifestations across various CTDs.
Main Results:
- High-resolution CT is highly sensitive for detecting parenchymal lung disease and potentially reversible lesions in CTD patients.
- Specific HRCT patterns can help distinguish CTD-related interstitial pneumonia from idiopathic interstitial pneumonia.
- Understanding common pulmonary manifestations aids in tailored diagnostic and management strategies.
Conclusions:
- Radiologists play a key role in the early diagnosis and management of lung disease in connective tissue disease patients.
- HRCT is an invaluable tool for assessing pulmonary involvement in CTDs.
- A systematic approach to recognizing CTD-associated lung disease improves patient outcomes.
Related Concept Videos
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...